[Effect of roxithromycin on inflammatory cytokine production in nasal polyp fibroblasts].
Kamakazu
Kiyoaki
K
Sasano
Kazuhito
K
Yamamoto
Sumiko
S
Suzaki
Harumi
H
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D018946:Chemokine CCL5 / Q000378:metabolism*; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D005347:Fibroblasts / Q000378:metabolism*; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism*; D015850:Interleukin-6 / Q000378:metabolism*; D016209:Interleukin-8 / Q000378:metabolism*; D009297:Nasal Mucosa / Q000166:cytology* / Q000378:metabolism; D009298:Nasal Polyps / Q000378:metabolism*; D015575:Roxithromycin / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D018946:Chemokine CCL5; D018836:Inflammation Mediators; D015850:Interleukin-6; D016209:Interleukin-8; D015575:Roxithromycin